Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.

Area of Science:

• Hematology
• Oncology
• Clinical Pathology

Background:

• Multiparameter flow cytometry (FCM) is more sensitive than cytology for detecting malignant cells in initial cerebrospinal fluid (CSF) specimens from patients with hematologic malignancies.
• The utility of FCM in analyzing subsequent CSF specimens remains unclear, necessitating optimized testing strategies.

Purpose of the Study:

• To develop and validate an algorithm for CSF testing in hematologic malignancies to reduce low-yield FCM tests while maintaining clinical accuracy.
• To establish an evidence-based approach for efficient CSF analysis in this patient population.

Main Methods:

• A two-cohort study (derivation and validation) involving patients with hematologic malignancies.
• Development of an algorithm: initial samples tested with both cytology and FCM; subsequent samples with cytology only, unless prior FCM was positive, then FCM is used.
• Sensitivity and specificity of the algorithm were evaluated against standard testing protocols.

Main Results:

• The algorithm demonstrated high sensitivity (90.0% in derivation, 87.5% in validation) and perfect specificity (100%) in both cohorts.
• The algorithm successfully reduced the number of FCM tests without missing clinically significant findings that would alter patient management.
• Missed cases did not impact management due to pre-existing central nervous system disease or treatment response.

Conclusions:

• The proposed algorithm provides an evidence-based method to optimize CSF testing in hematologic malignancies.
• This approach effectively reduces unnecessary FCM testing, thereby improving efficiency and potentially lowering costs without compromising patient care.
• The algorithm supports a more judicious use of FCM in the follow-up assessment of CSF in patients with hematologic malignancies.